The first 90 days of warfarin, age 80 years, and international normalized ratio (INR) 4.0 were associated with increased risk despite trial-leel anti coagulation control.

 
  • 在开始的90天,与抗凝组相对照,年龄80岁以上其国际标准化比值(INR)为4.;0者与风险增加有关联(尽管试验水平的抗凝治疗,在开始华法林治疗的90天,年龄80岁以上及国际标准化比值(INR)为4
今日热词
目录 附录 查词历史